Treatment of Intrabony Periodontal Defects With Platelet‐Rich Plasma Versus Platelet‐Poor Plasma Combined With a Bovine‐Derived Xenograft: A Controlled Clinical Trial

Abstract

Within its limits, these results suggest that the outcomes of the treatment after PRP/BDX and PPP/BDX applications in intrabony defects are similar. When the platelet counts are taken into consideration, PPP seems to demonstrate similar clinical efficacy as the PRP.